I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2022
* Seven key clinical milestones achieved year-to-date, including positive data readouts for lemzo...
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2021
* Financial results demonstrate strong fundamentals * Twenty key clinical milestones achieved ye...
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Hong Kong Market for the Treatment of Adults With Locally Advanced Or Metastatic Cholangiocarcinoma With A FGFR2 Fusion Or Rearrangement That Have Progressed After At Least One Prior Line Of Systemic Therapy
SAN FRANCISCO and SUZHOU, China, Jan. 24, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) ...
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020
- Results from two studies of BAVENCIO® to be featured in ASCO press briefing - Primary efficacy, b...
Data From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
- Not intended for US-, Canada- or UK-based media - ASCO Abstract # BAVENCIO® (avelumab): LBA1, 506...
Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy
SAN FRANCISCO and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) ...
BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine
Not intended for US-, Canada- and UK-based media DARMSTADT, Germany, and NEW YORK, Sept. 18, 2020 ...
European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma
Not intended for US, Canada and UK-based media -- EU approval based on JAVELIN Renal 101 trial re...
SIHL's Performance has Stabilized Against the Adverse Environment, with Strong Resilience of the Group's Business Structure
Focused on Transformation of ESG Value HONG KONG, March 31, 2023 /PRNewswire/ -- Shanghai Industria...
Born2Global's Picks - The 10 Most Promising Unicorns
SEOUL, South Korea, Aug. 14, 2019 /PRNewswire/ -- There has been a relative lack of emerging "unico...
BAMF Health and Telix complete first total-body PET scans with Illuccix for prostate cancer imaging
Telix and BAMF Health use Illuccix® (kit for the preparation of Gallium Ga 68 gozetotide injection)...
New Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care
Not intended for distribution in the USA, Canada or the UK Key ESMO Abstracts # BAVENCIO® (avelu...
Global Times: Xizang in the New Era: Why are boarding schools embraced by residents in Xizang?
BEIJING, Nov. 13, 2023 /PRNewswire/ -- Majestic snow-capped mountains, vast grasslands, and deep go...
Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
* New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subg...
Fosun International Issues ESG Report 2021：Sustain Resilience and Develop Business for Good to Empower the Future
HONG KONG, April 27, 2022 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fos...
Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter
MELBOURNE, Australia, April 17, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix...
Ascentage Pharma Announces 2022 Interim Results
SUZHOU, China and ROCKVILLE, Md. , Aug. 26, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a glob...
Tencent Music Entertainment Group Announces Second Quarter 2023 Unaudited Financial Results
SHENZHEN, China, Aug. 15, 2023 /PRNewswire/ -- Tencent Music Entertainment Group ("TME," or the "Co...
ASH 2022 | Ascentage Pharma to Present Data of Olverembatinib (HQP1351) in Three Oral Reports, Including the First Dataset from the First US Study, at the ASH Annual Meeting
SUZHOU, China, and ROCKVILLE, Md., Nov. 3, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a glob...
Asia Innovations Group, a Leading Mobile Social Platform in Emerging Markets, to Become a Publicly Listed Company Through Merger with Magnum Opus Acquisition Limited (NYSE: OPA)
Largest Consumer Internet SPAC Merger announced YTD in 2022 SINGAPORE and NEW YORK, Sept. 30, 2022...